Greg S. Garfield's most recent trade in NeuroPace Inc was a trade of 18,253 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 13, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NeuroPace Inc | Greg S. Garfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 18,253 | 18,253 | - | - | Stock Option (Right to Buy) | |
| NeuroPace Inc | Greg S. Garfield | Director | 26 Apr 2021 | 5,595,493 | 5,614,384 | - | 0 | Common Stock | ||
| NeuroPace Inc | Greg S. Garfield | Director | 26 Apr 2021 | 5,271,902 | 0 | - | - | Series B Preferred Stock | ||
| NeuroPace Inc | Greg S. Garfield | Director | 26 Apr 2021 | 323,591 | 0 | - | - | Series A Preferred Stock | ||
| NeuroPace Inc | Greg S. Garfield | Director | 26 Apr 2021 | 18,891 | 18,891 | - | 0 | Common Stock | ||
| NeuroPace Inc | Greg S. Garfield | Director | 26 Apr 2021 | 18,032 | 0 | - | - | Series B Preferred Stock | ||
| NeuroPace Inc | Greg S. Garfield | Director | 26 Apr 2021 | 859 | 0 | - | - | Series A Preferred Stock |